Details werden geladen...
FDA Approves Dostarlimab for Rectal Cancer
The PD-1 inhibitor could help patients avoid chemotherapy, radiation, and surgery, according to the drug's maker.
Ähnliche Seiten
Intratumoral Immunotherapy Draws Attention but Does It Work?
https://www.medscape.com/viewarticle/intratumoral-immunotherapy-draws-renewed-attention-does-it-2026a10012vxFDA Recall Problems Raise Questions About Safety, Liability
https://www.medscape.com/viewarticle/fda-device-recall-problems-raise-questions-about-patient-2026a10011czFDA Approves Atezolizumab With Chemo Combo for Colon Cancer
https://www.medscape.com/viewarticle/fda-approves-atezolizumab-chemo-combo-colon-cancer-2026a10011yaFDA Expands Anktiva Approval in Bladder Cancer
https://www.medscape.com/viewarticle/fda-expands-anktiva-approval-bladder-cancer-2026a10012nhHow Scientists Finally Cracked RAS in Pancreatic Cancer
https://www.medscape.com/viewarticle/how-scientists-finally-cracked-ras-pancreatic-cancer-2026a10010ok